Integrated Biopharma Inc (INBP) insider trading
Every open-market stock purchase and sale by Integrated Biopharma Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- No open-market insider trades in the last 12 months.
- No open-market insider buys on record.
Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales). Last close $0.18 on Jun 24, 2026.
Recent INBP insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jun 24, 2026 | Eric J Friedman (Director) | Bought (not open market) | — |
| Jun 24, 2026 | Robert Canarick (Director) | Bought (not open market) | — |
| Jun 24, 2026 | Eric J Friedman (Director) | Bought (not open market) | — |
| Jun 24, 2026 | Damon DeSantis (10% owner) | Bought (not open market) | — |
| Jun 24, 2026 | William H. Milmoe (Director) | Bought (not open market) | — |
| Apr 15, 2026 | William H. Milmoe (Director) | Sold (not open market) | — |
| Apr 15, 2026 | William H. Milmoe (Director) | Sold (not open market) | — |
| Apr 15, 2026 | William H. Milmoe (Director) | Sold (not open market) | — |
| Apr 15, 2026 | William H. Milmoe (Director) | Sold (not open market) | — |
| Apr 15, 2026 | Carl Desantis (10% owner) | Sold (not open market) | — |
| Apr 15, 2026 | Carl Desantis (10% owner) | Sold (not open market) | — |
| Apr 15, 2026 | Damon DeSantis (10% owner) | Bought (not open market) | — |
| Apr 15, 2026 | Damon DeSantis (10% owner) | Bought (not open market) | — |
| Mar 24, 2026 | Damon DeSantis (Director) | Bought (not open market) | — |
| Mar 24, 2026 | Carl Desantis (10% owner) | Sold (not open market) | — |
| Mar 24, 2026 | Carl Desantis (10% owner) | Sold (not open market) | — |
| Mar 24, 2026 | William H. Milmoe (10% owner) | Sold (not open market) | — |
| Mar 24, 2026 | William H. Milmoe (10% owner) | Sold (not open market) | — |
| Mar 24, 2026 | Damon DeSantis (Director) | Bought (not open market) | — |
| Dec 9, 2025 | Christina Kay (CEO) | Bought (not open market) | — |
| Dec 9, 2025 | Sheppard Riva (CEO) | Bought (not open market) | — |
| Dec 9, 2025 | Dina Masi (CFO) | Bought (not open market) | — |
Who's trading INBP
- Robert Canarick, Director: other filings, last Jun 24, 2026
- Damon DeSantis, Director: other filings, last Jun 24, 2026
- Eric J Friedman, Director: other filings, last Jun 24, 2026
- William H. Milmoe, 10% owner: other filings, last Jun 24, 2026
- Carl Desantis, 10% owner: other filings, last Apr 15, 2026
- Sheppard Riva, CEO: other filings, last Dec 9, 2025
- Christina Kay, CEO: other filings, last Dec 9, 2025
- Dina Masi, CFO: other filings, last Dec 9, 2025
Get free alerts when an insider at Integrated Biopharma Inc files a new trade →